Design Therapeutics, Inc. (DSGN) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $193.0K | -43.2% |
| 2024 | $340.0K | +32.8% |
| 2023 | $256.0K | -72.1% |
| 2022 | $918.0K | -40.3% |
| 2021 | $1.54M | +1923.7% |
| 2020 | $76.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $193.0K | -43.2% |
| 2024 | $340.0K | +32.8% |
| 2023 | $256.0K | -72.1% |
| 2022 | $918.0K | -40.3% |
| 2021 | $1.54M | +1923.7% |
| 2020 | $76.0K | — |